On-Demand

Hamilton’s Newest PAT Innovation: Revolutionizing In-Line Glucose Monitoring in Bioprocessing

Time
1 hour
Jump to Registration

Glucose plays a vital role in cell culture performance — directly impacting cell growth, viability, and product quality. Yet, real-time glucose control remains a blind spot in most upstream processes, with labs still relying on off-line or at-line measurements or complex spectroscopic systems

With its latest sensor innovation, Hamilton Process Analytics delivers a major leap forward: the first reusable, in-situ optical glucose sensor designed specifically for mammalian cell culture bioreactors.

Purpose-built for upstream bioprocessing, this groundbreaking technology offers:

  • Real-time glucose insight from Day 1 — without multivariate models or laser safety concerns
  • A robust, fiber-optic-free design, fully compatible with autoclave workflows
  • Proven performance in fed-batch and perfusion CHO processes
  • Seamless integration into existing PG 13.5 ports and digital/analog OT architectures (RS485, Modbus 4–20 mA)

Join our exclusive webinar to learn how this innovation is reshaping glucose control for scientists and engineers working in upstream bioprocessing.

Product Launch Webinar Image

Speakers

  • Giovani Campolongo

    Giovanni Campolongo

    Senior Market Segment Manager Process Analytics, Hamilton
  • Smiling professional with long dark hair, wearing a dark blazer, against a white background.

    Dr. Sherin Panikulam

    Scientific Associate, Bioprocess Technology Group – Institute for Pharma Technology and Biotechnology – FHNW Muttenz

On-Demand webinar registration